DBV TECHNOLOGIES Aktie [WKN DE: A1JWB7 / ISIN: FR0010417345]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Historisch	Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu DBV TECHNOLOGIES

15.12.20		Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2020 (GlobeNewswire)
24.11.20		DBV Technologies Announces Leadership Changes (GlobeNewswire)
11.11.20		Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2020 (GlobeNewswire)
10.11.20		DBV Technologies to Highlight Data on Viaskin™ Peanut Treatment Delivery and Patient Experience at ACAAI 2020 (GlobeNewswire)
09.11.20		DBV Technologies to Participate in Upcoming Investor Conferences (GlobeNewswire)
02.11.20		DBV Technologies Announces Filing and Validation of Marketing Authorization Application for Viaskin™ Peanut by European Medicines Agency (GlobeNewswire)
30.10.20		DBV Technologies Reports September 30, 2020 Cash Position (GlobeNewswire)
08.10.20		Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2020 (GlobeNewswire)
15.09.20		Monthly information regarding the total number of voting rights and total number of shares of the Company as of August 31, 2020 (GlobeNewswire)
09.09.20		DBV Technologies Announces Leadership Changes (GlobeNewswire)
02.09.20		DBV Technologies to Participate in Multiple September Investor Conferences (GlobeNewswire)
12.08.20		Monthly information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2020 (GlobeNewswire)
04.08.20		DBV Technologies Receives Complete Response Letter from FDA for Viaskin Peanut BLA in Children Ages 4-11 Years (GlobeNewswire)
31.07.20		DBV Technologies Reports First Half 2020 Financial Results (GlobeNewswire)
20.07.20		Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF (GlobeNewswire)
15.07.20		Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2020 (GlobeNewswire)
10.07.20		DBV Technologies Announces Publication of PEOPLE Phase III Open-Label Extension Study Evaluating Viaskin Peanut in The Journal of Allergy and Clinical Immunology (GlobeNewswire)
26.06.20		DBV Technologies Provides Operational and Business Update (GlobeNewswire)
11.06.20		Monthly information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2020 (GlobeNewswire)
04.06.20		DBV Technologies to Present Data on Epicutaneous Immunotherapy and Food Allergy Quality of Life at EAACI Digital Congress 2020 (GlobeNewswire)
02.06.20		DBV Technologies To Present at the Goldman Sachs 41st Annual Global Healthcare Conference (GlobeNewswire)
12.05.20		Information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2020 (GlobeNewswire)
30.04.20		DBV Technologies Reports March 31, 2020 Cash Position (GlobeNewswire)
20.04.20		DBV Technologies Announces Results of its 2020 Ordinary and Extraordinary General Meeting (GlobeNewswire)
15.04.20		Monthly information regarding the total number of voting rights and total number of shares of the Company (GlobeNewswire)
10.04.20		Ordinary and Extraordinary General Meeting of April 20, 2020 to be Held in Closed Virtual Session Due to COVID-19 Pandemic (GlobeNewswire)
30.03.20		Ordinary and Extraordinary General Meeting of April 20, 2020 (GlobeNewswire)
26.03.20		Monthly information regarding the total number of voting rights and total number of shares of the Company (GlobeNewswire)
20.03.20		DBV Technologies Announces Filing of 2019 Universal Registration Document and 2019 Annual Report on Form 20-F (GlobeNewswire)
17.03.20		Monthly information regarding the total number of voting rights and total number of shares of the Company as of February 29, 2020 and March 4, 2020 (GlobeNewswire)
16.03.20		DBV Technologies Provides Update on Viaskin Peanut BLA for Children Ages 4-11 Years (GlobeNewswire)
04.03.20		DBV Technologies Reports Full-Year 2019 Financial Results and Provides Business Update (GlobeNewswire)
04.03.20		DBV Technologies Announces Closing of Underwriters’ Option to Purchase Additional Ordinary Shares in the Form of American Depositary Shares in Connection With its Global Offering (GlobeNewswire)
02.03.20		DBV Technologies Announces Partial Exercise of Underwriters’ Option to Purchase Additional Shares in Connection With its Global Offering of Ordinary Shares in the Form of American Depositary Shares (A (GlobeNewswire)
24.02.20		DBV Technologies to Present Detailed Safety and Efficacy Data of Viaskin Peanut at AAAAI 2020 (GlobeNewswire)
21.02.20		DBV Technologies Announces FDA Advisory Committee Meeting to Review Viaskin Peanut for the Treatment of Peanut Allergy in Children (GlobeNewswire)
10.02.20		DBV Technologies to Present at the SVB Leerink 9th Annual Global Healthcare Conference (GlobeNewswire)
07.02.20		Monthly information regarding the total number of voting rights and total number of shares of the Company as of January 31, 2020 and February 4, 2020 (GlobeNewswire)
06.02.20		DBV Technologies Announces Appointment of Pascal Wotling as Chief Technical Operations Officer (GlobeNewswire)
04.02.20		DBV Technologies Announces Closing of Global Offering (GlobeNewswire)
30.01.20		DBV Technologies Announces Pricing of $153.7 million (€139.8 million) Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares (GlobeNewswire)
29.01.20		DBV Technologies Announces the Launch of a Proposed Global Offering of Ordinary Shares, Which May Be in the Form of American Depositary Shares, and Reports December 31, 2019 Cash Position (GlobeNewswire)
15.01.20		Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF (GlobeNewswire)
14.01.20		Monthly information regarding the total number of voting rights and total number of shares of the Company (GlobeNewswire)
08.01.20		DBV Technologies Reports Positive Three-Year, Long-Term Data from the PEOPLE Phase III Open-Label Extension Study of Viaskin Peanut in Children with Peanut Allergy (GlobeNewswire)
02.01.20		DBV Technologies Announces Appointment of Ramzi Benamar as Chief Financial Officer (GlobeNewswire)
10.12.19		Monthly information regarding the total number of voting rights and total number of shares of the Company (GlobeNewswire)
19.11.19		Monthly information regarding the total number of voting rights and total number of shares of the Company (GlobeNewswire)
05.11.19		DBV Technologies to Present at the Stifel 2019 Healthcare Conference (GlobeNewswire)
29.10.19		Ausblick: DBV TECHNOLOGIES stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net)

Zurück | 1 | 2 | 3 | 4 | Weiter

Newssuche

Meistgelesene Nachrichten

Bitcoin Kurs Prognose: Absturz auf 90.000 US-Dollar bereits diese Woche?

EQS-CMS: Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München: Release of a capital market information

Trump stellt erneut US-Rolle bei Vereinten Nationen infrage

ams-OSRAM-Aktie schächelt: ams-OSRAM erhält EU-Freigabe für staatliche Förderung aus Österreich

Investieren in die Zukunft: Diese 5 Quantencomputing-Aktien sind vielversprechend

Bundestagswahl in Deutschland: Union laut Hochrechnungen klar vorn, FDP scheitert an Fünf-Prozent-Hürde - SPD verliert deutlich

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2025 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	25.02.2025 18:11
Kaufwert:	EUR
	Hinzufügen Speichern